Cargando…

Stop the pain: study protocol for a randomized-controlled trial

BACKGROUND: Functional abdominal pain (FAP) is not only a highly prevalent disease but also poses a considerable burden on children and their families. Untreated, FAP is highly persistent until adulthood, also leading to an increased risk of psychiatric disorders. Intervention studies underscore the...

Descripción completa

Detalles Bibliográficos
Autores principales: Warschburger, Petra, Calvano, Claudia, Becker, Sebastian, Friedt, Michael, Hudert, Christian, Posovszky, Carsten, Schier, Maike, Wegscheider, Karl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171565/
https://www.ncbi.nlm.nih.gov/pubmed/25212457
http://dx.doi.org/10.1186/1745-6215-15-357
_version_ 1782335911511457792
author Warschburger, Petra
Calvano, Claudia
Becker, Sebastian
Friedt, Michael
Hudert, Christian
Posovszky, Carsten
Schier, Maike
Wegscheider, Karl
author_facet Warschburger, Petra
Calvano, Claudia
Becker, Sebastian
Friedt, Michael
Hudert, Christian
Posovszky, Carsten
Schier, Maike
Wegscheider, Karl
author_sort Warschburger, Petra
collection PubMed
description BACKGROUND: Functional abdominal pain (FAP) is not only a highly prevalent disease but also poses a considerable burden on children and their families. Untreated, FAP is highly persistent until adulthood, also leading to an increased risk of psychiatric disorders. Intervention studies underscore the efficacy of cognitive behavioral treatment approaches but are limited in terms of sample size, long-term follow-up data, controls and inclusion of psychosocial outcome data. METHODS/DESIGN: In a multicenter randomized controlled trial, 112 children aged 7 to 12 years who fulfill the Rome III criteria for FAP will be allocated to an established cognitive behavioral training program for children with FAP (n = 56) or to an active control group (focusing on age-appropriate information delivery; n = 56). Randomization occurs centrally, blockwise and is stratified by center. This study is performed in five pediatric gastroenterology outpatient departments. Observer-blind assessments of outcome variables take place four times: pre-, post-, 3- and 12-months post-treatment. Primary outcome is the course of pain intensity and frequency. Secondary endpoints are health-related quality of life, pain-related coping and cognitions, as well as selfefficacy. DISCUSSION: This confirmatory randomized controlled clinical trial evaluates the efficacy of a cognitive behavioral intervention for children with FAP. By applying an active control group, time and attention processes can be controlled, and long-term follow-up data over the course of one year can be explored. TRIAL REGISTRATION: DRKS00005038 (date: 25 July 2013); NCT02030392 (date: 7 January 2014) ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1745-6215-15-357) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4171565
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-41715652014-09-24 Stop the pain: study protocol for a randomized-controlled trial Warschburger, Petra Calvano, Claudia Becker, Sebastian Friedt, Michael Hudert, Christian Posovszky, Carsten Schier, Maike Wegscheider, Karl Trials Study Protocol BACKGROUND: Functional abdominal pain (FAP) is not only a highly prevalent disease but also poses a considerable burden on children and their families. Untreated, FAP is highly persistent until adulthood, also leading to an increased risk of psychiatric disorders. Intervention studies underscore the efficacy of cognitive behavioral treatment approaches but are limited in terms of sample size, long-term follow-up data, controls and inclusion of psychosocial outcome data. METHODS/DESIGN: In a multicenter randomized controlled trial, 112 children aged 7 to 12 years who fulfill the Rome III criteria for FAP will be allocated to an established cognitive behavioral training program for children with FAP (n = 56) or to an active control group (focusing on age-appropriate information delivery; n = 56). Randomization occurs centrally, blockwise and is stratified by center. This study is performed in five pediatric gastroenterology outpatient departments. Observer-blind assessments of outcome variables take place four times: pre-, post-, 3- and 12-months post-treatment. Primary outcome is the course of pain intensity and frequency. Secondary endpoints are health-related quality of life, pain-related coping and cognitions, as well as selfefficacy. DISCUSSION: This confirmatory randomized controlled clinical trial evaluates the efficacy of a cognitive behavioral intervention for children with FAP. By applying an active control group, time and attention processes can be controlled, and long-term follow-up data over the course of one year can be explored. TRIAL REGISTRATION: DRKS00005038 (date: 25 July 2013); NCT02030392 (date: 7 January 2014) ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/1745-6215-15-357) contains supplementary material, which is available to authorized users. BioMed Central 2014-09-11 /pmc/articles/PMC4171565/ /pubmed/25212457 http://dx.doi.org/10.1186/1745-6215-15-357 Text en © Warschburger et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Study Protocol
Warschburger, Petra
Calvano, Claudia
Becker, Sebastian
Friedt, Michael
Hudert, Christian
Posovszky, Carsten
Schier, Maike
Wegscheider, Karl
Stop the pain: study protocol for a randomized-controlled trial
title Stop the pain: study protocol for a randomized-controlled trial
title_full Stop the pain: study protocol for a randomized-controlled trial
title_fullStr Stop the pain: study protocol for a randomized-controlled trial
title_full_unstemmed Stop the pain: study protocol for a randomized-controlled trial
title_short Stop the pain: study protocol for a randomized-controlled trial
title_sort stop the pain: study protocol for a randomized-controlled trial
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4171565/
https://www.ncbi.nlm.nih.gov/pubmed/25212457
http://dx.doi.org/10.1186/1745-6215-15-357
work_keys_str_mv AT warschburgerpetra stopthepainstudyprotocolforarandomizedcontrolledtrial
AT calvanoclaudia stopthepainstudyprotocolforarandomizedcontrolledtrial
AT beckersebastian stopthepainstudyprotocolforarandomizedcontrolledtrial
AT friedtmichael stopthepainstudyprotocolforarandomizedcontrolledtrial
AT hudertchristian stopthepainstudyprotocolforarandomizedcontrolledtrial
AT posovszkycarsten stopthepainstudyprotocolforarandomizedcontrolledtrial
AT schiermaike stopthepainstudyprotocolforarandomizedcontrolledtrial
AT wegscheiderkarl stopthepainstudyprotocolforarandomizedcontrolledtrial